当前位置:首页 - 行情中心 - 昊帆生物(301393) - 财务分析 - 利润表

昊帆生物

(301393)

  

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入328,158,737.06225,057,269.4291,229,728.71388,794,947.08
营业收入328,158,737.06225,057,269.4291,229,728.71388,794,947.08
二、营业总成本228,599,500.59151,713,429.6861,494,588.69278,567,768.72
营业成本191,553,471134,681,268.2256,531,270.9238,901,601.25
税金及附加2,553,778.661,857,431.67600,805.242,534,550.13
销售费用9,686,865.687,533,851.662,182,431.6111,953,266.28
管理费用23,460,639.1515,265,464.085,731,275.7724,014,515.35
研发费用26,225,248.0916,908,969.9610,389,895.9928,474,913.58
财务费用-24,880,501.99-24,533,555.91-13,941,090.82-27,311,077.87
其中:利息费用34,786.5622,939.9816,356.3345,270.77
其中:利息收入28,050,784.1623,623,486.5112,439,672.8527,497,756.52
加:公允价值变动收益8,537,868.521,848,635.62277,995.89224,295.89
加:投资收益1,172,551.34168,632.16-1,509,192.19
资产处置收益-58,976.15---129.48
资产减值损失(新)-1,369,210.16-2,777,892.49634,404.65-4,533,662.8
信用减值损失(新)-3,248,675.25-2,965,500.21-1,253,202.7-560,202.28
其他收益6,400,906.925,842,163.574,774,574.415,695,511.36
营业利润平衡项目0000
四、营业利润110,993,701.6975,459,878.3934,168,912.27112,562,183.24
加:营业外收入118,889.22115,874.22101,495.0129,197.74
减:营业外支出565,246.74104,005.1141,247.5105,515.45
利润总额平衡项目0000
五、利润总额110,547,344.1775,471,747.534,229,159.78112,485,865.53
减:所得税费用14,212,148.529,662,664.284,400,320.0413,512,111
六、净利润96,335,195.6565,809,083.2229,828,839.7498,973,754.53
持续经营净利润96,335,195.6565,809,083.2229,828,839.7498,973,754.53
归属于母公司股东的净利润96,335,195.6565,809,083.2229,828,839.7498,973,754.53
(一)基本每股收益0.90.610.281.07
(二)稀释每股收益0.890.610.281.07
九、综合收益总额96,335,195.6565,809,083.2229,828,839.7498,973,754.53
归属于母公司股东的综合收益总额96,335,195.6565,809,083.2229,828,839.7498,973,754.53
公告日期2024-10-302024-08-282024-04-262024-04-09
审计意见(境内)标准无保留意见
TOP↑